Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part I

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 6, 2004, Pages 466-471

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cancer; Cardiovascular disease; Cholesterol; Heart disease; Prostate cancer; Statins

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PLACEBO; REFECOXIB; SELENIUM; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT;

BREAST CANCER; CANCER PREVENTION; CANCER SCREENING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DIET SUPPLEMENTATION; DYSLIPIDEMIA; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; ADULT; FEMALE; MALE; METHODOLOGY; NEOPLASM; REVIEW;

ADULT; ANTICARCINOGENIC AGENTS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHEMOPREVENTION; CLINICAL TRIALS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NEOPLASMS;

EID: 18844404324     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.10.001     Document Type: Conference Paper

References (31)

1. R.O. Bonow Primary prevention of cardiovascular disease a call to action Circulation 106 2002 3140 3141
2. J. Stamler, M.L. Daviglus, D.B. Garside Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality JAMA 284 2000 311 318
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
4. S.M. Grundy Early detection of high cholesterol levels in young adults JAMA 284 2000 365 367
5. B. Fisher, J.P. Costantino, D.L. Wickerham Tamoxifen for prevention of breast cancer report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371 1388
6. I.M. Thompson, P.J. Goodmaan, C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
7. M.A. Moyad The ABCs of Nutrition and Supplements for Prostate Cancer 2000 JW Edwards Publishing Ann Arbor
8. O.P. Heinonen, D. Albanes, J. Virtamo Prostate cancer and supplementation with alpha-tocopherol and beta-carotene incidence and mortality in a controlled trial J Natl Cancer Inst 90 1998 440 446
9. The ATBC Study Group Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation a postintervention follow-up JAMA 290 2003 476 485
10. L.C. Clark, G.F. Combs Jr, B.W. Turnbull Nutritional Prevention of Cancer Study Group Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial JAMA 276 1996 1957 1963
11. R.S. Eidelman, D. Hollar, P.R. Hebert Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease Arch Intern Med 164 2004 1552 1556
12. W.J. Blot, J.Y. Li, P.R. Taylor Nutrition intervention trials in Linxian, China supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population J Natl Cancer Inst 85 1993 1483 1492
13. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029 1035
14. N.G. Stephens, A. Parsons, P.M. Schofield Randomised controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study (CHAOS) Lancet 347 1996 781 786
15. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
16. Heart Outcomes Prevention Evaluation Study Investigators Vitamin E supplementation and cardiovascular events in high-risk patients N Engl J Med 342 2000 154 160
17. Collaborative Group of the Primary Prevention Project Low-dose aspirin and vitamin E in people at cardiovascular risk a randomized trial in general practice Lancet 357 2001 89 95
18. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals a randomized placebo-controlled trial Lancet 360 2002 23 33
19. M.A. Moyad Selenium and vitamin E supplements for prostate cancer evidence or embellishment? Urology 59 suppl. 4A 2002 9 19
20. S. Yusuf Two decades of progress in preventing vascular disease Lancet 360 2002 2 3
21. D.D. Waters, E.L. Alderman, J. Hsia Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women a randomized controlled trial JAMA 288 2002 2432 2440
22. B.G. Brown, X.Q. Zhao, A. Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592 2001
23. M. Sonnleithner, K. Jeschke, L. Bayer Dyslipoproteinemia as a risk factor in prostate cancer J Urol 169 2003 76 [abstract 294].
24. M.A. Moyad, D. Giacherio, J.E. Montie National Prostate Cancer Coalition American Urologic Association Meeting 2005 (submitted for publication).
25. M.A. Moyad The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy part I-lifestyle changes Curr Opin Urol 13 2003 137 145
26. M.A. Moyad The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy part II-rapid review of dietary supplements Curr Opin Urol 13 2003 147 151
27. M.A. Moyad, P.R. Carroll Lifestyle recommendations to prevent prostate cancer, part I time to redirect our attention? Urol Clin N Am 31 2004 289 300
28. M.A. Moyad, P.R. Carroll Lifestyle recommendations to prevent prostate cancer, part II time to redirect our attention? Urol Clin N Am 31 2004 301 311
29. W. Demark-Wahnefried, C.N. Robertson, P.J. Walther Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen Urology 63 2004 900 904
30. D. Ornish, W. Fair, E. Pettengill Can lifestyle changes reverse prostate cancer? J Urol 169 2003 74 [abstract 286].
31. W. Demark-Wahnefried, D.T. Price, T.J. Polascik Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features Urology 58 2001 47 52